Evidence map›Paper›PMID 40813554›Full record

ArticleTranslational stroke research2025

Identification of Ischemic Stroke Patients Based on Plasma Concentrations of Extracellular Vesicles.

Naomi C Buntsma, Chi M Hau, Mandy Los, Vivien M Chen, Ton G van Leeuwen, Yvo B W E M Roos, Rienk Nieuwland, Aleksandra Gasecka, Edwin van der Pol

Abstract read
In one paragraph

Article in Translational stroke research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Measurement of extracellular vesicles using flow cytometry: friend or foe?Research and practice in thrombosis and haemostasis · 2026
    Article
  3. The Dilution Paradox in Extracellular Vesicle Flow Cytometry.Journal of extracellular vesicles · 2026
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Naomi C BuntsmaLaboratory of Experimental Clinical Chemistry and Amsterdam Vesicle Center, Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. n.c.buntsma@amsterdamumc.nl.ORCID http://orcid.org/0000-0003-3201-7205
Chi M HauLaboratory of Experimental Clinical Chemistry and Amsterdam Vesicle Center, Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0404-8517
Mandy LosLaboratory of Experimental Clinical Chemistry and Amsterdam Vesicle Center, Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Vivien M ChenConcord Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney Australia Haematology, Concord Hospital and ANZAC Research Institute, Sydney Local Health District, Sydney, Australia.ORCID http://orcid.org/0000-0001-5119-7470
Ton G van LeeuwenBiomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-5642-1133
Yvo B W E M RoosDepartment of Neurology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9205-5882
Rienk NieuwlandLaboratory of Experimental Clinical Chemistry and Amsterdam Vesicle Center, Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-5394-2152
Aleksandra GaseckaLaboratory of Experimental Clinical Chemistry and Amsterdam Vesicle Center, Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-5083-7587
Edwin van der PolLaboratory of Experimental Clinical Chemistry and Amsterdam Vesicle Center, Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. e.vanderpol@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-9497-8426

Funding

Dutch Heart Foundation CINTICS 2018B031European Union PHOREVER 101093171Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek VIDI 19724
6 · The paper itself

Abstract

Patients presenting with stroke symptoms suffer from either ischemic stroke, hemorrhagic stroke, transient ischemic attacks (TIA), or "stroke mimics," which include benign headaches, epilepsy, and vestibular disorders. As ischemic and hemorrhagic stroke patients require different medical treatments, early identification of the underlying cause of symptoms is essential for tailored and urgent medical intervention. This study investigates whether extracellular vesicles (EVs), present in peripheral blood of patients presenting with stroke symptoms, can be used to identify patients with ischemic stroke. Blood was collected from 155 patients presenting with stroke symptoms in the emergency room and analyzed for EVs by flow cytometry (ethics approval number NL72929.018.20). The primary endpoint was to compare platelet EV concentrations between patients with (n = 66) and without (n = 89) ischemic stroke. Concentrations of EVs from both activated platelets and leukocytes were lower in patients presenting with ischemic stroke compared to other patients (p = 0.038 and p = 0.015, respectively). No significant differences in other EV types were observed. In addition, ischemic stroke patients were older and had a higher diastolic blood pressure compared to patients with other diagnoses. In a multivariable analysis, leukocyte EVs and diastolic blood pressure were independent indicators of ischemic stroke. To conclude, this study demonstrates that the plasma concentration of leukocyte EVs can be useful to identify ischemic stroke patients in an emergency setting.

Indexed as

Extracellular VesiclesIschemic StrokeAgedAged, 80 and overBiomarkersBlood PlateletsFemaleHumansLeukocytesMaleMiddle AgedBiomarkersAcute cerebrovascular accidentBiomarkersExtracellular vesiclesFlow cytometryStroke

Identifiers

PMID40813554
PMCPMC12596396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.